Key facts
- This page summarizes Kristen Landon's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2025, 21:23.
Kristen Landon - 17 Jan 2025 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- SXTP
- Reported as of
- 17 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Aug 2025, 21:23:53 UTC
- Prior SEC filing
- 14 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristen Landon
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kristen Landon filed Form 4 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 14 Aug 2025.
Change
- Previous filing in this sequence was filed on 14 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002053910
Primary reporting owner
Landon Kristen
- Relationship
- Chief Operating Officer
- Address
- C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON
- Signature
- /s/ Kristen Landon
- Signature date
- 14 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SXTP
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,540
- Change %
- Price
- $0.000000
- Shares after
- 4,540
- Date
- 17 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This Form 4 is being filed late due to an inadvertent administrative error.
Footnote F2
The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.